Denis Healy

Title: Denis Healy: Innovator in Cancer Treatment

Introduction

Denis Healy is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on combining specific antibodies with agonists to enhance treatment efficacy.

Latest Patents

Denis Healy holds 1 patent for a method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist. This patent describes combination therapies that include an antibody specifically binding to human CCR4 and a selective 4-1BB agonist. The disclosure emphasizes the use of these combination therapies for effective cancer treatment.

Career Highlights

Throughout his career, Denis has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.

Collaborations

Denis has collaborated with talented individuals in his field, including Chia-Yang Lin and Shihao Chen. These partnerships have played a crucial role in advancing his research and patent development.

Conclusion

Denis Healy's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in medical therapies.